News and Events

June 8, 2010

Boot Camp for MedTech Entrepreneurs

This event has been rescheduled to fall 2010.

April 21, 2010

BIOMEDevice Forum

Join us for the third annual BIOMEDevice Executive Forum as we focus on convergence and cross-sector collaborations among biotechnology, medical device, IVD, and pharmaceutical companies. This two-day conference will provide you with the resources you need to strengthen connections between key stakeholders involved in investing, partnering, licensing, and developing business opportunities in the rapidly growing market for innovative healthcare products. Topics addressed at this year's Forum will include:

Regulatory & Reimbursement Issues
Partnering & Collaborations
Intellectual Property & Finance
Technology & Innovation

News Stories from MassDevice.com:

July 30, 2010

Insurers who thought the public plan was a threat have another thing coming

Employers who promote individual health will have the greatest success at lowering employees' health care expenditures.
Read this story on MassDevice.com

July 30, 2010

Cardiac Science Q2 losses soar on recall costs

Cardiac Science Corp. earnings take big dip due to an $11 million recall charge
Read this story on MassDevice.com

July 30, 2010

Wall Street punishes Thoratec for lofty aspirations

Shares plunge by double digit percentages despite solid quarter where the Pleasenton, Calif. heart pump maker boosts bottom line 765 percent.
Read this story on MassDevice.com

July 30, 2010

Plunging Taxus sales continue to put the hurt on Angiotech

Earnings at Angiotech Pharmaceuticals Inc. show that royalty revenues derived from sales of Boston Scientific Corp.'s Taxus drug-eluting stent continue dropped by 50 percent during Q2.
Read this story on MassDevice.com

July 30, 2010

Covidien wins reversal of Becton Dickinson needle patents suit

A federal appeals court tosses a trial judge's $58 million damage award for Becton, Dickinson & Co. in the lastest round of a patent battle with Covidien Plc. over safety syringes.
Read this story on MassDevice.com

July 30, 2010

Mass. Life Sciences Center adds Taligen Therapeutics CEO to board

Massachusetts Governor Deval Patrick appoints Taligen Therapeutics CEO Abbie Celniker to the Mass. Life Sciences Center board of directors.
Read this story on MassDevice.com

July 30, 2010

CRL spikes $1.6 billion WuXi merger over shareholder concerns

Charles River Laboratories Inc. says it has terminated the merger agreement with WuXi PharmaTech (Cayman) Inc. over shareholder objections; Will pay $30 million break up fee.
Read this story on MassDevice.com

July 30, 2010

Now Back to Sales

To know him is to love him. But would you take him home?
Read this story on MassDevice.com

July 30, 2010

Insulet Corp. records 57% jump in 2Q revenues

Tubeless insulin-infusion device manufacturer Insulet Corp. racks up $22.9 million in second-quarter revenues, $8.2 million higher than year-ago sales, but profits remain a distant goal
Read this story on MassDevice.com

July 29, 2010

BD's profits shrink 10 percent on tax provision

Becton, Dickinson and Company's profits drop 10 percent during the third quarter on a $34 million income tax provision; firm expands share repurchase program to $700 million.
Read this story on MassDevice.com

July 29, 2010

FDA requires nine makers of needleless connectors to conduct post-market surveillance

Baxter, Carefusion and Becton Dickinson among nine companies told by federal regulators to study connections between displaced needleless connectors and higher rates of blood stream infections.
Read this story on MassDevice.com

July 29, 2010

Medtronic aims to mitigate heart failure woes through the spine

Medtronic Inc. launches a global, randomized clinical trial of spinal cord stimulation as a treatment for slowing the progression of heart failure.
Read this story on MassDevice.com

July 29, 2010

Zoll posts 285 percent increase in profits during Q3

Chelmsford, Mass-based Zoll Medical Corp. records another strong quarter based on increased sales in it's emergency medical services market.
Read this story on MassDevice.com

July 29, 2010

Palomar's losses surge 600 percent

Palomar Medical Technologies Inc. second quarter losses increases 600 percent due to heavy spending in G&A and R&D expenditures; company says revenue growth was "steady."
Read this story on MassDevice.com

July 29, 2010

Acquisitions pay off for Covidien in Q3, despite flat sales.

VNUS and Aspect Medical Systems buyouts boost the company's medical device business as Covidien Plc. posts $364 million profit on 2.6 billion in sales.
Read this story on MassDevice.com

July 29, 2010

Tailoring the message to reach the accountable care organization mandate

In the new healthcare environment, it will also be necessary for medical device companies to communicate to its customers that they can help them achieve the broader goals associated with Accountable Care Organizations.
Read this story on MassDevice.com

July 29, 2010